TLX agonist 2 (compound 31) is a TLX agonist (EC50=0.1 µM, Kd=0.16 µM). TLX agonist 2 promotes TLX transcriptional activity and enhances the expression of TLX target genes by binding to TLX. TLX agonist 2 can be used in the study of neurodegenerative diseases[1].
Molecular Weight:
453.42
Formula:
C23H18F3N5O2
Target:
Orphan Nuclear Receptor,Orphan Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
